GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could patients stop anti-rejection drugs sooner after transplant?
Disease control Not yet recruitingThis study tests whether it is safe to stop the anti-rejection drug tacrolimus early after a stem cell transplant. About 50 people with blood cancers or bone marrow disorders will receive a modern GVHD prevention method and then stop tacrolimus by day 88. The goal is to see if th…
Matched conditions: GVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 01, 2026 15:25 UTC
-
New hope for young transplant patients: drug combo may prevent deadly immune attack
Disease control Not yet recruitingThis study tests whether adding the drug vorinostat to standard medications can prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood or immune disorders who receive a bone marrow transplant. About 55 participants will receive …
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC